Navigation Links
PAREXEL International Reports First Quarter Fiscal Year 2013 Results
Date:10/31/2012

le adjustment to restructuring reserves, and a charge relating to a dispute.  The net effect of these items reduced GAAP pre-tax income by $355,000.  In addition, the Company excluded tax expense of approximately $2.8 million which included one-time adjustments to deferred tax assets related to intangible assets and executive compensation.  The overall impact on net income from all of the above-mentioned adjustments was approximately $2.4 million.

During the first quarter, the Company purchased approximately 1.49 million shares of its common stock for approximately $54.8 million under its previously announced $200 million Share Repurchase Program, which was implemented in September 2012.  The Company acquired approximately 1.33 million shares at the outset of the Accelerated Share Repurchase (ASR) Program and is expecting to receive additional shares once the program is completed.  In addition, the Company purchased approximately 157,000 shares in the open market through a 10b5-1 plan.  As of September 30, 2012, approximately $145.2 million remained available under the Share Repurchase Program for the purchase of additional shares. 

On a segment basis, service revenue for the first quarter of Fiscal Year 2013 was $297.2 million in Clinical Research Services (CRS), $48.4 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $49.2 million in Perceptive Informatics, Inc.

Backlog at the end of September 2012 was approximately $4.54 billion, an increase of 25.7% year-over-year.  The reported backlog included gross new business wins in the quarter of $669.3 million, cancellations of $188.2 million, and a positive impact from foreign exchange rates of $55.0 million. The net book-to-bill ratio was 1.22 in the quarter.

Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer stated, "For the first quarter, we reported strong year-over-year revenue growth with incre
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
2. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
3. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
4. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
5. PAREXEL International to Present at J.P. Morgan Healthcare Conference
6. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
7. ABTCP: Internationale Krise beeinflusst den Papier- und Zellstoffmarkt, doch Brasilien investiert weiterhin in Innovationen
8. BioSpain 2012 is Larger in Terms of Internationalisation and the Number of Exhibitors, Meetings and Visitors
9. PROLOR Biotech To Present Data On Its Long-Acting Human Growth Hormone At International NeuroEndocrine Meeting
10. VWR International, LLC Acquires Sovereign Group
11. Ohio State Hosting International Personalized Health Care Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), ... it has priced an underwritten registered offering of 3,900,000 ... $9.00 per share, and granted the underwriters in the ... additional 585,000 shares of its common stock. The gross ... is expected to close on May 6, 2015, subject ...
(Date:5/1/2015)... -- Investor-Edge has initiated coverage on ... GENE ), Agilent Technologies Inc. (NYSE: A ... ), Sequenom Inc. (NASDAQ: SQNM ), and ... report on Genetic Technologies can be accessed at ... the NASDAQ Composite ended at 4,941.42, down 1.64%, ...
(Date:4/30/2015)... South Carolina (PRWEB) May 01, 2015 ... system services, is extremely proud to announce that for ... been named as a winner of a Queen’s Award ... success for the design and manufacture of a unique ... is the revolutionary alternative to traditional steam flow measurement. ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... chemicals, today announced that it has commenced an underwritten public ... to grant the underwriters a 30-day option to purchase ... of common stock offered in the public offering. The ... be no assurance as to whether or when the ...
Breaking Biology Technology:BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 4Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 5Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3
... International,Corporation (Nasdaq: PRXL ) announced today that ... be presenting at the Thomas,Weisel Partners Healthcare Conference ... September 7th at 8:35 a.m. ET. A live ... "Investor Relations Webcasts",section of PAREXEL,s web site at ...
... 5 Hyperion,Therapeutics, a biopharmaceutical company focused on ... for the,treatment of Urea Cycle Disorders (UCD) and ... B financing. Leading the round was,Sofinnova Ventures, with ... of Menlo Park, CA. WRF Capital of Seattle, ...
... Cryopreservation Expert, BOTHELL, Wash., Sept. 5 ... developer and marketer of,proprietary hypothermic storage and cryopreservation ... the expansion of its Scientific,Advisory Board (SAB) with ... quality and regulatory assurance and in cryopreservation of ...
Cached Biology Technology:PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 2Hyperion Therapeutics Secures $40 Million In Series B Round 2BioLife Solutions Expands Scientific Advisory Board 2BioLife Solutions Expands Scientific Advisory Board 3BioLife Solutions Expands Scientific Advisory Board 4
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
(Date:3/23/2015)... March 23, 2015 SoundView Technology Group issues a ... NXTD ) Wocket smart wallet. SoundView was one of the ... their experience with the Wocket in multiple scenarios and outlets. ... Foods and other retailers, making both debit and credit card ... also says, "If the company meets their plans in 2015, ...
(Date:3/23/2015)... -- In the 2014 fiscal year, irs.gov recorded over $100 ... accounts for a fraction of the estimated losses for ... $11 billion globally. The polygraph has traditionally been used ... Investor Mark Saint Juste along with former ... partnered to administer the test in a new way: ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... unused agricultural land could produce enough biomass to meet ... the environment, according to research led by Professor Gail ... funded by the UK Energy Research Centre (UKERC), is ... at the potential of planting short rotation coppice (poplar ...
... will not only teach us more about the way neurons ... diagnostics and therapies for neurological diseases such as Parkinson,s," says ... take a major toll on society. More than 8% of ... cent suffers from a mental disturbance and the number of ...
... Avila Therapeutics, Inc., a biotechnology company developing novel ... a scientific review article in Nature Reviews Drug ... www.nature.com/reviews/drugdisc , Vol. 10, April 2011, Singh, J.). ... and how structural bioinformatics coupled with structure-based drug design ...
Cached Biology News:Short rotation energy crops could help meet UK's renewable energy targets 2Skywalker ensures optimal communication between neurons 2New opportunities for covalent drugs published by Avila scientists 2
... excluding l-[U-14C]methionine, 1.85 MBq, 50 uCi. ... > 1.85 GBq/mg atom carbon, ... Mixture of Ala, Arg, Asp, Glu, ... Pro, Ser, Thr, Tyr and Val.1.85 ...
Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
Request Info...
... Checker Kits provide two highly efficient methods ... time-consuming plasmid preparation. By using the large-scale ... need to do is to transfer partial ... the transformation plates into the solutions provided ...
Biology Products: